IFNA1 and melanoma: Meta-analysis of 15 adjuvant trials of adjuvant interferon (IFN)-alpha and long-term follow-up of the EORTC 18952 trial of adjuvant IFN found ulceration of the primary melanoma was the key determinant for IFN sensitivity10,11.